An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of ...
1don MSN
Jeremy Clarkson reveals prostate cancer news – 5 things men over 60 need to know about the disease
Prostate cancer is very common but is shrouded in misconceptions ...
Prostate cancer starts in the prostate, a small gland located below the bladder that is responsible for secreting one of the components of semen. Prostate cells may grow out of control and become ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.
Orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
Both are effective but work in slightly different ways: The newer of the two, lutetium-177, which was approved by the U.S. Food and Drug Administration (FDA) in 2022, can treat cancer that has ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.
A cancer researcher has explained why many men choose not to have any treatment ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Alcohol is part of many people’s social lives, ...
The metastatic prostate cancer market is undergoing a major transition from conventional ADT toward combination-based, biomarker-driven, and precision-targeted treatment approaches. While AR pathway ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results